Literature DB >> 6362661

The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.

P E Carter, B Dunbar, J E Fothergill.   

Abstract

Human complement component C1s was purified from fresh blood by conventional methods of precipitation and chromatography. The single-chain zymogen form was activated by treatment with C1r. Reduction and carboxymethylation then allowed the light chain and heavy chain to be separated on DEAE-Sepharose CL-6B in 8 M-urea. Liquid-phase sequencing of the light chain determined 50 residues from the N-terminus. CNBr-cleavage fragments of the light chain were separated by high-pressure liquid chromatography on gel-permeation and reverse-phase columns. N-Terminal sequencing of these fragments determined the order of a further 138 residues, giving a total of 188 residues or about 75% of the light chain. Seven of these eight sequences could be readily aligned with the amino acid sequences of other serine proteinases. The typical serine proteinase active-site residues are clearly conserved in C1s, and the specificity-related side chain of the substrate-binding pocket is aspartic acid, as in trypsin, consistent with the proteolytic action of C1s on C4 at an arginine residue. Somewhat surprisingly, when the C1s sequence is compared with that of complement subcomponent C1r, the percentage difference (59%) is approximately the same as that found between the other mammalian serine proteinases (56-71%).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362661      PMCID: PMC1152437          DOI: 10.1042/bj2150565

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

2.  Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s.

Authors:  R B Sim; R R Porter
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

3.  Subunit composition and structure of subcomponent C1q of the first component of human complement.

Authors:  K B Reid; R R Porter
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

Review 4.  A molecular approach to the complement system.

Authors:  J E Fothergill; W H Anderson
Journal:  Curr Top Cell Regul       Date:  1978

5.  Structure of crystalline -chymotrypsin. V. The atomic structure of tosyl- -chymotrypsin at 2 A resolution.

Authors:  J J Birktoft; D M Blow
Journal:  J Mol Biol       Date:  1972-07-21       Impact factor: 5.469

6.  The purification and characterization of bovine C4, the fourth component of complement.

Authors:  N A Booth; R D Campbell; J E Fothergill
Journal:  Biochem J       Date:  1979-03-01       Impact factor: 3.857

7.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

8.  A general method for affinity purification of complement component C3b using factor H-sepharose.

Authors:  J D Scott; J E Fothergill
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

9.  Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.

Authors:  M A Smith; L M Gerrie; B Dunbar; J E Fothergill
Journal:  Biochem J       Date:  1982-11-01       Impact factor: 3.857

10.  Complete amino acid sequence of the catalytic chain of human complement subcomponent C1-r.

Authors:  G J Arlaud; J Gagnon
Journal:  Biochemistry       Date:  1983-04-12       Impact factor: 3.162

View more
  7 in total

1.  The cloning and expression of the aroL gene from Escherichia coli K12. Purification and complete amino acid sequence of shikimate kinase II, the aroL-gene product.

Authors:  G Millar; A Lewendon; M G Hunter; J R Coggins
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

2.  The overexpression, purification and complete amino acid sequence of chorismate synthase from Escherichia coli K12 and its comparison with the enzyme from Neurospora crassa.

Authors:  P J White; G Millar; J R Coggins
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

3.  Physicochemical and immunochemical characterization of allergenic proteins from rye-grass (Lolium perenne) pollen prepared by a rapid and efficient purification method.

Authors:  G P Cottam; D M Moran; R Standring
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

4.  The overexpression and complete amino acid sequence of Escherichia coli 3-dehydroquinase.

Authors:  K Duncan; S Chaudhuri; M S Campbell; J R Coggins
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

5.  Sequencing and overexpression of the Escherichia coli aroE gene encoding shikimate dehydrogenase.

Authors:  I A Anton; J R Coggins
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

6.  The amino acid sequence of the small monomeric phosphoglycerate mutase from the fission yeast Schizosaccharomyces pombe.

Authors:  J Nairn; N C Price; L A Fothergill-Gilmore; G E Walker; J E Fothergill; B Dunbar
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

7.  A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism.

Authors:  T C Tsang; D R Bentley; R S Mibashan; F Giannelli
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.